1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FUT4 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA C16orf87 CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA ABHD14A-ACY1 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA DUSP10 CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA CRYL1 CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA KIAA0930 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA LPCAT2 CTRPv2 pan-cancer AAC 0.18 7e-07
mRNA RPP25 CTRPv2 pan-cancer AAC 0.18 7e-07
mRNA ETV6 CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA HSD17B11 CTRPv2 pan-cancer AAC 0.18 8e-07
Download CSV